tradingkey.logo

Perrigo Company PLC

PRGO
查看詳細走勢圖
15.065USD
+0.125+0.84%
收盤 01/13, 16:00美東報價延遲15分鐘
2.07B總市值
虧損本益比TTM

Perrigo Company PLC

15.065
+0.125+0.84%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+0.84%

5天

+2.14%

1月

+14.65%

6月

-45.28%

今年開始到現在

+8.23%

1年

-38.11%

查看詳細走勢圖

TradingKey Perrigo Company PLC股票評分

單位: USD 更新時間: 2026-01-13

操作建議

Perrigo Company PLC當前公司基本面數據相對健康,增長潛力很大。當前估值合理,在藥品行業排名46/159位。機構持股佔比非常高,近一月多位分析師給出公司評級為持有。最高目標價為18.67。中期看,股價處於下降通道。近一個月,市場表現很強,技術面和基本面綜合得分較高,很強的走勢得到基本面和技術面的印證。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Perrigo Company PLC評分

相關信息

行業排名
46 / 159
全市場排名
143 / 4563
所屬行業
藥品

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

過冷
過熱
看跌

Perrigo Company PLC亮點

亮點風險
Perrigo Company plc is a provider of over the counter (OTC) health and wellness solutions that are designed to enhance individual well-being. Its segments include Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises of its consumer self-care business in the United States and Canada. It primarily provides its customers self-care products that are sold and marketed under the customer's own brands and/or exclusive brands. The CSCI segment comprises of its consumer self-care business outside of the United States and Canada, primarily in Europe and Australia. These products are developed, manufactured, marketed, and distributed by the Company. Its product categories include Upper Respiratory, Pain and Sleep-Aids, Skincare and Personal Hygiene, Digestive Health, and Nutrition. Its primary branded products are sold under brand names Compeed, Dr. Fresh, Firefly, Good Sense, Mederma, Nasonex, Solpadeine, Coldrex, and Physiomer, among others.
利潤高增長
公司淨利潤處於行業前列,最新年度總收入4.37B美元
估值合理
公司最新PE估值-40.08,處於3年歷史合理位
機構減倉
最新機構持股155.20M股,環比減少9.33%
Keeley-Teton 顧問公司持倉
明星投資者Keeley-Teton 顧問公司持倉,最新持倉375.68K股
活躍度增加
近期活躍度增加,過去20天平均換手率0.25

分析師目標

基於 4 分析師
持有
評級
18.667
目標均價
+23.78%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Perrigo Company PLC新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Perrigo Company PLC簡介

Perrigo Company plc is a provider of over the counter (OTC) health and wellness solutions that are designed to enhance individual well-being. Its segments include Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises of its consumer self-care business in the United States and Canada. It primarily provides its customers self-care products that are sold and marketed under the customer's own brands and/or exclusive brands. The CSCI segment comprises of its consumer self-care business outside of the United States and Canada, primarily in Europe and Australia. These products are developed, manufactured, marketed, and distributed by the Company. Its product categories include Upper Respiratory, Pain and Sleep-Aids, Skincare and Personal Hygiene, Digestive Health, and Nutrition. Its primary branded products are sold under brand names Compeed, Dr. Fresh, Firefly, Good Sense, Mederma, Nasonex, Solpadeine, Coldrex, and Physiomer, among others.
公司代碼PRGO
公司Perrigo Company PLC
CEOLockwood-Taylor (Patrick)
網址https://www.perrigo.com/

常見問題

Perrigo Company PLC(PRGO)的當前股價是多少?

Perrigo Company PLC(PRGO)的當前股價是 15.065。

Perrigo Company PLC 的股票代碼是什麼?

Perrigo Company PLC的股票代碼是PRGO。

Perrigo Company PLC股票的52週最高點是多少?

Perrigo Company PLC股票的52週最高點是30.930。

Perrigo Company PLC股票的52週最低點是多少?

Perrigo Company PLC股票的52週最低點是12.170。

Perrigo Company PLC的市值是多少?

Perrigo Company PLC的市值是2.07B。

Perrigo Company PLC的淨利潤是多少?

Perrigo Company PLC的淨利潤為-171.80M。

現在Perrigo Company PLC(PRGO)的股票是買入、持有還是賣出?

根據分析師評級,Perrigo Company PLC(PRGO)的總體評級為持有,目標價格為18.667。

Perrigo Company PLC(PRGO)股票的每股收益(EPS TTM)是多少

Perrigo Company PLC(PRGO)股票的每股收益(EPS TTM)是-0.376。
KeyAI